CD34+ cells are isolated from human umbilical cord blood using positive immunomagnetic separation techniques from a single or pooled cord blood unit(s) resulting in > 95% viability and > 90% purity. Certificate of Analysis is included. Cord Blood units are collected from donors following IRB-approved protocols and/or in accordance with local, state and national regulatory requirements.
The below products are subject to availability. Please inquire using the Request More Information button below.
For research use only. Not for use in diagnostic procedures.
Feature | Specification |
---|---|
Packaging | Vial, 1.8 mL, CD34+ cells frozen in 10% DMSO cryopreservation medium |
CD34+ cells are isolated from human umbilical cord blood using positive immunomagnetic separation techniques from a single or pooled cord blood unit(s) resulting in > 95% viability and > 90% purity. Certificate of Analysis is included. Cord Blood units are collected from donors following IRB-approved protocols and/or in accordance with local, state and national regulatory requirements.
The below products are subject to availability. Please inquire using the Request More Information button below.
For research use only. Not for use in diagnostic procedures.
Overview
CD34 is a glycosylated transmembrane protein that serves as established marker of hematopoietic stem and progenitor cells. Umbilical Cord Blood (CB) is a rich source of CD34+ hematopoietic stem and progenitor cells (HSPCs), a rare and primitive population of multipotent cells that can give rise to all blood cell types.
Due to their superior proliferation, differentiation, and self-renewal, cord blood-derived CD34+ stem cells are an advantageous choice for a wide range of research including genome editing, immune regulation, hematopoiesis, and regenerative medicine.
Our CD34+ stem cells are derived from ethically sourced human umbilical cord blood collected using IRB protocols and/or in accordance with local, state and federal requirements. We use positive immunomagnetic techniques to isolate the cells resulting in a highly enriched population of CD34+ cells with exceptional viability.
What To Expect
Key Features
Available Cell Counts
Potential Research Applications
Benefits of Using CD34+
CD34+ cells derived from umbilical cord blood (UCB) offer several advantages compared to those obtained from other sources of CD34+ cells, including:
Application |
Research
|
---|---|
Packaging |
Vial, 1.8 mL, CD34+ cells frozen in 10% DMSO cryopreservation medium
|
Shelf Life |
1.0 year from receipt at < -135°C
|
Shipping Conditions |
Shipped in Dry Ice
|
Special Ordering Information |
Orders must be placed by 12 pm (EST) to be shipped that day. Orders after 12 pm (EST) will be shipped the following day. Orders placed after 12PM EST on Thursday will not ship until the following Monday due to dry ice requirements.
|
Storage Conditions |
Liquid Nitrogen Vapor Phase
|
Unit Size |
2 Million Cells (Single Donor)
|
Are you looking for resources, click on the resource type to explore further.
Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.
We are here to answer your questions.